Doctors Ponder FDA Drug Controversy
15218
Startling testimony by an FDA drug safety reviewer about five popular medications has the medical world buzzing about how tightly the agency should be regulating new medications.
44020
Nearly 20 percent of U.S. Food and  Drug Administration scientists surveyed in late 2002 said they  were pressured to approve or recommend approval of a medicine  despite their reservations about the drug's risks or  effectiveness, according to documents made public on Thursday.
719234
US Food and Drug Administration staff reviewers on Tuesday questioned clinical data for non-Hodgkin&#39;s lymphoma drug Marqibo, made by Inex Pharmaceuticals Corp.
95505
The recent Vioxx withdrawal and  testimony from an FDA insider accusing the agency of failing to  protect public health are fueling such heightened concern over  drug safety that valuable medicines could be kept from  patients, doctors said on Friday.
404405
Dr. Steven Galson, acting director of the Food and Drug Administration&#39;s Center for Drug Evaluation, announced Friday that the FDA will review five popular drugs whose safety is being questioned.
158802
Critics charge conflict of interest in a system where pharmaceutical giants fund the regulatory process.
631592
A report last week tying the Type 2 diabetes pill Avandia to increased risk for heart attack and heart-related deaths prompted a flood of calls to local doctors and Internet postings from patients seeking advice about whether to continue taking the commonly prescribed medication.
105165
Advisers to the U.S. Food and Drug Administration on Friday will consider the risks of drug-coated stents in patients with medical complications who are not approved for the artery-opening heart devices.
287777
Federal regulators Thursday urged doctors to think twice before prescribing several popular and controversial painkillers to their patients with histories of heart trouble.
458921
Congress is looking into whether the Food and Drug Administration ignored safety concerns about the drug raised by its own reviewers and outside scientists.
512837
Washington --- The Food and Drug Administration, accused in recent weeks of being cozy with the pharmaceutical industry, must open its practices to greater public scrutiny, says a top official of the agency&#39;s besieged Office of New Drugs.
55594
Questions about popular medications may cause a consumer backlash against the tendency to take pills for "lifestyle" concerns, which could hurt the beleaguered drug industry.
458929
U.S. health officials said on Friday  they would review whether to take regulatory action over Merck  & Co Inc and Schering-Plough's cholesterol medicine Vytorin  following the drug's failure to work better than a generic drug  in a study of plaque build-up in neck arteries.
131994
Doctors are struggling to decide which pain relievers to prescribe now that they know that drugs like Vioxx and Celebrex pose serious heart risks.
101261
Following results of recent clinical trials on popular cholesterol drugs, cardiologists are questioning whether a patientâs cholesterol should be all that matters.
767854
Nearly 20 percent of U.S. Food and Drug Administration scientists surveyed in late 2002 said they were pressured to approve or recommend approval of a medicine despite their reservations about the drug's risks or effectiveness, according to documents made public on Thursday.
130259
SOME of Britainâs most popular medicines are to be reviewed by drug regulators after claims by an American scientist that they pose severe risks to patients and should not be prescribed.